CANTON, Conn., March 16, 2023 /PRNewswire/ — Kelyniam Global (OTC: KLYG), a maker of custom cranial implants, today announced results for its year ended December 31, 2022. “2022 was the sixth year in a row that Kelyniam has meaningfully increased sales while successfully competing…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.